Related Experiment Video

Updated: Feb 12, 2026

A Preclinical Murine Model of Hepatic Metastases
06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

30.5K

Anti-angiogenic therapies in brain metastases

Anna S Berghoff1, Matthias Preusser1

  • 1Department of Medicine I and Comprehensive Cancer Center Central Nervous System Tumours Unit (CCC-CNS), Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.

Memo
|April 3, 2018
PubMed

Insights

Brain metastases pose a significant challenge in oncology. This review examines anti-angiogenic therapies, focusing on their efficacy in treating brain metastases by targeting neo-angiogenesis.

Area of Science:

  • Oncology
  • Neuro-oncology
  • Cancer Biology

Background:

  • Brain metastases represent a significant clinical challenge in cancer care.
  • Limited treatment options exist for patients with symptomatic brain metastases.
  • Neo-angiogenesis is a key factor in brain metastasis development.

Purpose of the Study:

  • To review current data on the efficacy of neo-angiogenic therapies for brain metastases.
  • To explore the potential of anti-angiogenic strategies in managing brain metastases.

Main Methods:

  • Literature review of existing studies on neo-angiogenic therapies in brain metastases.
  • Analysis of clinical data regarding the effectiveness of these treatments.

Main Results:

  • Neo-angiogenesis is a critical process in the formation of brain metastases.
  • Anti-angiogenic therapies show promise as a preventive and therapeutic approach.
  • Current data on efficacy is being summarized to guide future research.

Conclusions:

  • Targeting neo-angiogenesis is a potential strategy for managing brain metastases.
  • Further research is needed to fully establish the role of anti-angiogenic therapies.
  • Anti-angiogenic therapy may offer new avenues for patients with limited options.
Keywords:
AsymptomaticBevacizumabCNS metastasesSymptomaticSystemic treatment

More Related Videos

Anti-RDL and Anti-mGlutR1 Receptors Antibody Testing in Honeybee Brain Sections using CRISPR-Cas909:25

Anti-RDL and Anti-mGlutR1 Receptors Antibody Testing in Honeybee Brain Sections using CRISPR-Cas9

Published on: January 30, 2020

8.6K
In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts11:07

In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts

Published on: August 14, 2019

7.5K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
460
Behavior Therapy01:22

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
735
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
304
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.3K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.3K